Eli Lilly

Indianapolis, Indiana
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

Eli Lilly is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Eli Lilly embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.

View Full Corporate Bias Ratings Report

Board Bias

Expand Summary

CEO of Eli Lilly

David A. Ricks

David A. Ricks

Summary:

Headquartered in Indianapolis, Indiana, Eli Lilly is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. David A. Ricks serves as CEO/President and Chairman, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $385,250 to Republican causes and $113,137 to Democratic causes. Under their tenure, Eli Lilly currently holds a 'High Risk' risk rating.

View Full Board Bias Report

Political Contributions of Leadership:

$385,250

$113,137

Republican

Democrat

Shareholder Proposals

Expand Summary

Date
ESG Category
Proponent
Summary of ResolutionMgmt RecTotal Vote % in Favor
5/6/24CommonSpirit HealthAdoption of a human rights policyAgainstN/A
5/6/24John CheveddenEliminate Supermajority Voting RequirementsAgainstN/A
5/6/24Trinity HealthReport on Impact of Patent Process on Product AccessAgainstN/A
5/6/24As You Sow on behalf of Marguerite Casey FoundationReport on the Effectiveness of the Company's Diversity, Equity, and Inclusion EffortsAgainstN/A
5/6/24SEIU Master TrustDisclosing Lobbying ActivityAgainstN/A
5/1/23GovernanceCommonSpirit HealthReport on Lobbying Values CongruencyAgainst22.50%
5/1/23SocialNational Center for Public PolicyReport on Risks of Supporting AbortionAgainst1.90%
5/1/23GovernanceChange FinanceRequire Indirect Political Spending ReportingAgainst4.10%
5/1/23SocialTrinity HealthReport on Impact of Patent Process on Product AccessAgainst10.40%
5/1/23GovernanceJohn CheveddenEliminate Supermajority Voting RequirementsAgainst40.70%
5/1/23SocialAs You Sow, on behalf of Leslie Oelsner Bene IRA of S Berman (S), Sarah B Sonnenfeld Rev Tr (S), Curtis Overway and Marcelina Cravat-OverwayGreater Disclosure of Material Corporate DiversityAgainst27.10%
5/1/23SocialAs You SowReport on the Effectiveness of the Company's Diversity, Equity, and Inclusion EffortsAgainst27.10%
5/1/23GovernanceSEIU Master TrustReport Disclosing Lobbying ActivityAgainst31.40%
5/2/22GovernanceTrinity HealthReport Oversight of Risks Related to Anticompetitive Pricing StrategiesAgainst22.78%
5/2/22SocialCommonSpirit HealthDisclose Lobbying Activities & Alignment with Public Policy PositionsAgainst34.00%
5/2/22GovernanceLegal & General Invest. Mgmt. America, Inc.Independent Board ChairAgainst34.54%
5/2/22SocialSEIU Master TrustReport on Lobbying Payments and PolicyAgainst37.03%
Generate Reports
Clear
Toast